Catalyst Wire Dossier Catalyst Wire Dossier

HEPARIN SODIUM

HEPARIN SODIUM · Hospira, Inc.
Drug timelines are a Plus or Pro feature.

150 regulatory and trial events tracked for HEPARIN SODIUM, covering 2006-10-04 to 2026-02-20. Get the full timeline:

Most recent: FDA Approved: HEPARIN SODIUM — Supplemental Application (Meitheal Pharmaceuticals Inc.)

See pricing